Caroline Vanhulle

Gosselies, WAL 6041, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription.

Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription.

Journal: Research square
Published: June 12, 2026

Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription.

Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription.

Journal: Research square
Published: June 12, 2026

Identification of the cellular transcription factor KLF16 as a novel repressive epigenetic repressor of HIV-1 transcription.

Identification of the cellular transcription factor KLF16 as a novel repressive epigenetic repressor of HIV-1 transcription.

Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026

Formation of polyploid giant cancer cells and the transformative role of human cytomegalovirus IE1 protein.

Formation of polyploid giant cancer cells and the transformative role of human cytomegalovirus IE1 protein.

Journal: Cancer letters
Published: March 27, 2025

Novel role of UHRF1 in the epigenetic repression of the latent HIV-1.

Novel role of UHRF1 in the epigenetic repression of the latent HIV-1.

Journal: EBioMedicine
Published: September 02, 2021

Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization.

Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization.

Journal: Nucleic acids research
Published: June 22, 2021

Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments.

Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: February 16, 2019

Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir.

Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir.

Journal: AIDS (London, England)
Published: October 19, 2016

Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites.

Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites.

Journal: Scientific reports
Published: August 01, 2016

Characterization of new RNA polymerase III and RNA polymerase II transcriptional promoters in the Bovine Leukemia Virus genome.

Characterization of new RNA polymerase III and RNA polymerase II transcriptional promoters in the Bovine Leukemia Virus genome.

Journal: Scientific reports
Published: May 09, 2016

Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.

Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1.

Journal: EMBO molecular medicine
Published: December 19, 2015

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.

Journal: Scientific reports
Published: October 09, 2015
Showing 1-12 of 13

Last Updated: 09/26/2026